IDH-C227
IDH-C227 is a potent and selective IDH1R132H inhibitor. IDH-C227 has anticancer effcts[1].
Product Specifications
CAS Number
1355324-14-9
UNSPSC
12352005
Target
Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/idh-c227.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(NCC(N(C(C2=C(C)C=CC=C2)C(NC3CCCCC3)=O)C4=CC(F)=CC=C4)=O)C=C1
Molecular Formula
C30H31FN4O2
Molecular Weight
498.59
References & Citations
[1]Hanumantha Rao Madala, et al. Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies. Cancers (Basel) . 2018 Feb 11;10 (2) :49.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IDH1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A00601-1-Cy3 100 µg/Vial
Anti-Prolactin/PRL Antibody Picoband®, Cy3 Conjugate
Sign In for Pricing
View Details 
30-1225-0.1 0.1 mg
Anti-PAG / Cbp Monoclonal Antibody (Clone:MEM-255)
Sign In for Pricing
View Details MBS7024095-01 0.02 mg
Recombinant NADH-quinone oxidoreductase subunit K (nuoK)
Sign In for Pricing
View Details